Frankfurt-am-Main, Germany

Ivica Fucek

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Hamburg, DE (2018)
  • Hattersheim, DE (2021)
  • Frankfurt-am-Main, DE (2015 - 2023)
  • Heidelberg, DE (2021 - 2024)

Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: **Ivica Fucek: Innovator in Antibody Engineering**

Introduction

Ivica Fucek is a prominent inventor based in Frankfurt-am-Main, Germany, known for his significant contributions to the field of antibody engineering. With a remarkable portfolio of 10 patents, his work primarily focuses on creating novel antigen-binding proteins aimed at addressing various malignancies.

Latest Patents

Fucek's latest patents include revolutionary advancements such as the bispecific EGFR/CD16 antigen-binding protein. This innovative protein is designed to engage natural killer (NK) cells towards EGFR-positive cells, providing promising therapeutic options for EGFR-positive malignancies. Additionally, he has developed multivalent FV antibodies, which pertain to a trispecific antibody molecule that integrates a diabody-unit into a polypeptide chain. This molecule offers enhanced binding capabilities, making strides towards more effective cancer treatments.

Career Highlights

Throughout his career, Ivica Fucek has been associated with leading biotechnology firms, including Affimed GmbH and Amphivena Therapeutics, Inc. His experiences at these companies have allowed him to refine his expertise in antibody design and application, fostering innovations that hold the potential to transform cancer therapeutics.

Collaborations

Fucek has collaborated with notable professionals in his field, including Kristina Ellwanger and Uwe Reusch. These collaborations have been key to advancing his research and patent filings, contributing to a richer understanding of antibody functionalities and their potential impacts on treatment methodologies.

Conclusion

Ivica Fucek stands out as a visionary inventor in the realm of antibody engineering. With his innovative patents and collaborative efforts, he is poised to make a significant impact in the fight against cancer. His dedication to advancing medical science through innovation is commendable and highlights the importance of continued research in the field of immunotherapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…